- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
- 10-K Annual report
- 10.99 Leave of Absence Agreement Dated January 4, 2007
- 21 Subsidiaries of the Registrant
- 23.1 Consent of Ernst & Young LLP
- 23.2 Consent of Haskell & White LLP
- 31.1 Section 302 Certification of the Chief Executive Officer
- 31.2 Section 302 Certification of the Chief Financial Officer
- 32 Section 906 Certification of the CEO and CFO
Exhibit 23.2
Consent of Haskell & White LLP, Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Form S-3 No. 333-138844, No. 333-108948, No. 333-112043 and No. 333-122026) of Cortex Pharmaceuticals, Inc. and in the related Prospectus and in the Registration Statements (Form S-8 No. 333-134490, No. 333-102042, No. 333-82477 and No. 333-20777) pertaining to the 2006 and 1996 Stock Incentive Plans and the Mark A. Varney Non-Qualified Stock Option Agreement dated January 30, 2006, the 1989 Incentive Stock Option, Nonqualified Stock Option and Stock Purchase Plan, the 1989 Special Nonqualified Stock Option and Stock Purchase Plan, and the Executive Stock Plan, of Cortex Pharmaceuticals, Inc. of our report dated February 27, 2007, with respect to the financial statements of Cortex Pharmaceuticals, Inc. included in its Annual Report on Form 10-K for year ended December 31, 2006.
/s/ HASKELL & WHITE LLP
Irvine, California
March 12, 2007